Research graph
References from Oral dual-targeted nanosystem for ameliorating colonic barrier injury and secondary liver injury. Local targets link to admitted publications; unresolved targets remain external evidence.
Tea (Camellia sinensis) ameliorates DSS-induced colitis and liver injury by inhibiting TLR4/NF-κB/NLRP3 inflammasome in mice
10.1016/j.biopha.2022.114136 · 2023 · External reference
Andrographolide sodium bisulfite ameliorates dextran sulfate sodium-induced colitis and liver injury in mice via inhibiting macrophage proinflammatory polarization from the gut-liver axis
10.1016/j.intimp.2022.109007 · 2022 · External reference
Ellagic acid prevented dextran-sodium-sulfate-induced colitis, liver, and brain injury through gut microbiome changes
10.3390/antiox12101886 · 2023 · External reference
Sodium orthovanadate protects against ulcerative colitis and associated liver damage in mice: insights into modulations of Nrf2/Keap1 and NF-κB
10.1007/s00210-024-03335-w · 2025 · External reference
Gut microbiota and intestinal immunity interaction in ulcerative colitis and its application in treatment
10.3389/fcimb.2025.1565082 · 2025 · External reference
Microbiome-based therapies in ulcerative colitis: mechanisms, clinical evidence, and a precision-medicine framework
10.3390/biomedicines14050969 · 2026 · External reference
Sanhuang xiexin decoction ameliorates secondary liver injury in DSS-induced colitis involve regulating inflammation and bile acid metabolism
10.1016/j.jep.2022.115682 · 2022 · External reference
From intestine to liver: a review of the pathological mechanisms of ulcerative colitis-induced secondary liver injury and targeted therapies with medicinal
10.1016/j.jnutbio.2026.110361 · 2026 · External reference
2′-fucosyllactose remits colitis-induced liver oxygen stress through the gut–liver–metabolites axis
10.3390/nu14194186 · 2022 · External reference
GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis
10.1016/j.ijbiomac.2024.134779 · 2024 · External reference
Prevention of colitis-induced liver oxidative stress and inflammation in a transgenic mouse model with increased omega-3 polyunsaturated fatty acids
10.1016/j.redox.2023.102803 · 2023 · External reference
The bsh1 gene of lactobacillus plantarum AR113 ameliorates liver injury in colitis mice
10.1038/s41538-025-00373-3 · 2025 · External reference
Ulcerative colitis
10.1016/s0140-6736(23)00966-2 · 2023 · External reference
Gut-liver axis: pathophysiological concepts and clinical implications
10.1016/j.cmet.2022.09.017 · 2022 · External reference
Gut–liver axis: barriers and functional circuits
10.1038/s41575-023-00771-6 · 2023 · External reference
Gut microbiota participates in polystyrene microplastics-induced hepatic injuries by modulating the gut−liver Axis
10.1021/acsnano.3c04449 · 2023 · External reference
Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease
10.3389/fimmu.2026.1870619 · 2026 · External reference
Polyphenol-rich extract of chrysanthemum × morifolium (Ramat) Hemsl. (Hangbaiju) prevents obesity and lipid accumulation through restoring intestinal microecological balance
10.3390/plants14152393 · 2025 · External reference
Oxidative stress-responsive fluorescent polymer nanoplatform regulate lipid metabolism through lipophagy
10.1016/j.saa.2025.126695 · 2026 · External reference
Resolvin D1 ameliorates hepatic steatosis by remodeling the gut microbiota and restoring the intestinal barrier integrity
10.1016/j.intimp.2021.108500 · 2022 · External reference
Probiotic delivery for editing of the gut microbiota to mitigate colitis and maintain hepatic homeostasis via gut−liver axis
10.1021/acsnano.5c00325 · 2025 · External reference
Emerging nanocarrier systems for the enhanced delivery of active pharmaceutical ingredients to the intestine
10.1080/17435889.2025.2520157 · 2025 · External reference
Recent insights and applications of nanocarriers-based drug delivery systems for colonic drug delivery and cancer therapy: an updated review
10.1016/j.critrevonc.2025.104646 · 2025 · External reference
Bioactive nanomotor enabling efficient intestinal barrier penetration for colorectal cancer therapy
10.1038/s41467-025-57045-9 · 2025 · External reference
Mannosylated chitosan–coated berberine hydrochloride cubosomal hydrogel for targeted macrophage-mediated wound healing
10.1007/s12247-026-10424-1 · 2026 · External reference
State of the art on tannin-based micro-/nano-carriers as drug delivery systems: a comprehensive review
10.4236/pp.2026.171001 · 2026 · External reference
Current advances in chitosan nanoparticles based oral drug delivery for colorectal cancer treatment
10.2147/ijn.s375229 · 2022 · External reference
ROS-responsive hydrogel delivering bio-nanoselenium for targeted therapy of UVB-induced skin photodamage
10.1021/acsami.6c00317 · 2026 · External reference
An oral immune enhancer with excellent biocompatibility for effectively strengthening body’s immunity and treating cancer
10.1016/j.apsb.2026.01.041 · 2026 · External reference
3D printing mesoporous silica nanoparticles/PCL with controlled drug release for pet deworming
10.1002/pat.70607 · 2026 · External reference
Arginine-loaded silica nanoparticles inhibit E. faecalis in root canals
10.1007/s10856-026-07034-1 · 2026 · External reference
A pH-responsive and nitric oxide-producing nanocarrier for targeted therapy of melanoma
10.1016/j.cej.2025.169985 · 2025 · External reference
Antimicrobial and physico-mechanical properties of a universal adhesive loaded with L-arginine-containing mesoporous silica nanoparticles (ArgC18@MSNs)
10.1016/j.dental.2025.08.004 · 2025 · External reference
Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota–brain interactions in colitis
10.1126/sciadv.adf3887 · 2023 · External reference
Mucus-penetrating silk fibroin-based nanotherapeutics for efficient treatment of ulcerative colitis
10.3390/biom12091263 · 2022 · External reference
A biomimetic nanoplatform for endogenous self-replenishing of oxygen to promote sonodynamic therapy for targeted ablation of activated macrophages in atherosclerotic plaques
2025 · External reference
Oral nanomotor-enabled mucus traverse and tumor penetration for targeted chemo-sono-immunotherapy
10.1002/smll.202203466 · 2022 · External reference
Mucus-penetrating polymeric nanoparticles for oral delivery of curcumin to inflamed colon tissue
10.1016/j.jddst.2019.04.030 · 2019 · External reference
Targeting fatty acid synthase with berberine promotes IL-10 production in macrophages and prevents relapse in a murine colitis model
10.1096/fj.202504287r · 2026 · External reference
Intestinal and hepatic benefits of BBR-EVO on DSS-induced experimental colitis in mice
2024 · External reference
Nitric oxide-driven nanomotors with bowl-shaped mesoporous silica for targeted thrombolysis
10.1016/j.jcis.2021.12.065 · 2022 · External reference
Nitric oxide-actuated titanium dioxide Janus nanoparticles for enhanced multimodal disruption of infectious biofilms
10.1002/adfm.202407626 · 2024 · External reference
